Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Kataja

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 11, 2013
Prostate cancer: ESMO Consensus Conference Guidelines 2012A Horwich, J Hugosson, T de Reijke, et al.
Scandinavian Journal of Urology and Nephrology|July 20, 2011
Does the outcome of prostate cancer patients with large prostates differ from small prostate size in permanent seed, low dose-rate brachytherapy?Sirpa H Aaltomaa, Vesa V Kataja, Atte Räty, et al.
Anticancer Research|March 1, 1997
Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancerM Eskelinen, V Kataja, E Hämäläinen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 27, 2009
Eight years experience of local prostate cancer treatment with permanent I125 seed brachytherapy--morbidity and outcome resultsSirpa H Aaltomaa, Vesa V Kataja, Tapani Lahtinen, et al.
International Journal of STD & AIDS|November 1, 1990
Prevalence of genital human papillomavirus infections in a mass-screened Finnish female population aged 20-65 yearsK Syrjänen, M Yliskoski, V Kataja, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 1, 2004
The surgical and oncological safety of immediate breast reconstructionP Mustonen, J Lepistö, A Papp, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy--a randomised studyI T Jantunen, T T Muhonen, V V Kataja, et al.
European Journal of Epidemiology|March 1, 1990
Prospective follow-up of genital HPV infections: survival analysis of the HPV typing dataV Kataja, K Syrjänen, S Syrjänen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Prognostic significance of TGF-alpha expression in breast cancerP K Auvinen, P K Lipponen, V V Kataja, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Safety and efficacy results of a randomized trial comparing adjuvant toremifene and tamoxifen in postmenopausal patients with node-positive breast cancer. Finnish Breast Cancer GroupK Holli, R Valavaara, G Blanco, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 11, 2013
Prostate cancer: ESMO Consensus Conference Guidelines 2012A Horwich, J Hugosson, T de Reijke, et al.
Scandinavian Journal of Urology and Nephrology|July 20, 2011
Does the outcome of prostate cancer patients with large prostates differ from small prostate size in permanent seed, low dose-rate brachytherapy?Sirpa H Aaltomaa, Vesa V Kataja, Atte Räty, et al.
Anticancer Research|March 1, 1997
Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancerM Eskelinen, V Kataja, E Hämäläinen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 27, 2009
Eight years experience of local prostate cancer treatment with permanent I125 seed brachytherapy--morbidity and outcome resultsSirpa H Aaltomaa, Vesa V Kataja, Tapani Lahtinen, et al.
International Journal of STD & AIDS|November 1, 1990
Prevalence of genital human papillomavirus infections in a mass-screened Finnish female population aged 20-65 yearsK Syrjänen, M Yliskoski, V Kataja, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 1, 2004
The surgical and oncological safety of immediate breast reconstructionP Mustonen, J Lepistö, A Papp, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy--a randomised studyI T Jantunen, T T Muhonen, V V Kataja, et al.
European Journal of Epidemiology|March 1, 1990
Prospective follow-up of genital HPV infections: survival analysis of the HPV typing dataV Kataja, K Syrjänen, S Syrjänen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Prognostic significance of TGF-alpha expression in breast cancerP K Auvinen, P K Lipponen, V V Kataja, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Safety and efficacy results of a randomized trial comparing adjuvant toremifene and tamoxifen in postmenopausal patients with node-positive breast cancer. Finnish Breast Cancer GroupK Holli, R Valavaara, G Blanco, et al.
Pageof 6